158 related articles for article (PubMed ID: 38646492)
1. Clinical prognostic significance of xeroderma pigmentosum group C and IFN‑γ in non‑small cell lung cancer.
Wang Y; Wang W; Wang H; Qin L; Zhang M; Zhang Y; Wang Y; Hao C; Qu M; Wang G
Oncol Lett; 2024 Jun; 27(6):259. PubMed ID: 38646492
[TBL] [Abstract][Full Text] [Related]
2. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
3. XPC Protein Improves Lung Adenocarcinoma Prognosis by Inhibiting Lung Cancer Cell Stemness.
Wang W; Ma S; Ding Z; Yang Y; Wang H; Yang K; Cai X; Li H; Gao Z; Qu M
Front Pharmacol; 2021; 12():707940. PubMed ID: 34803670
[No Abstract] [Full Text] [Related]
4. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells.
Chen JC; Ko JC; Taso YC; Cheng HH; Chen TY; Yen TC; Lin YW
Pharmacology; 2021; 106(3-4):154-168. PubMed ID: 33202406
[TBL] [Abstract][Full Text] [Related]
5. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients.
Bai X; Jin F; Fu Y; Yu Z; Zhao L; Ren J; Li Y; Jiao X; Zhao H; Yao W; Mi X; Wang E; Olopade OI; Zhou M; Wei M
Med Oncol; 2012 Sep; 29(3):1543-53. PubMed ID: 22038723
[TBL] [Abstract][Full Text] [Related]
7. 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells.
Chen JC; Ma PF; Lin YC; Wu CH; Peng YS; Zheng HY; Lin MC; Li YT; Lin YW
Pharmacology; 2018; 102(1-2):91-104. PubMed ID: 29953987
[TBL] [Abstract][Full Text] [Related]
8. Astaxanthin enhances erlotinib-induced cytotoxicity by p38 MAPK mediated xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells.
Chen JC; Wu CH; Peng YS; Zheng HY; Lin YC; Ma PF; Yen TC; Chen TY; Lin YW
Toxicol Res (Camb); 2018 Nov; 7(6):1247-1256. PubMed ID: 30555679
[TBL] [Abstract][Full Text] [Related]
9. XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression.
Cui T; Srivastava AK; Han C; Yang L; Zhao R; Zou N; Qu M; Duan W; Zhang X; Wang QE
Oncotarget; 2015 Apr; 6(12):10060-72. PubMed ID: 25871391
[TBL] [Abstract][Full Text] [Related]
10. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
11. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression.
Wu YH; Wu TC; Liao JW; Yeh KT; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10422-32. PubMed ID: 21056989
[TBL] [Abstract][Full Text] [Related]
12. Modulation of risk of squamous cell carcinoma head and neck in North Indian population with polymorphisms in xeroderma pigmentosum complementation Group C gene.
Yadav SK; Singh S; Gupta S; Brahma Bhatt ML; Mishra DP; Roy D; Sanyal S
J Cancer Res Ther; 2018; 14(3):651-657. PubMed ID: 29893334
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family.
Ali MZ; Blatterer J; Khan MA; Schaflinger E; Petek E; Ahmad S; Khan E; Windpassinger C
Mol Genet Genomic Med; 2020 Feb; 8(2):e1060. PubMed ID: 31923348
[TBL] [Abstract][Full Text] [Related]
14. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma Pigmentosum Group C Deficiency Alters Cigarette Smoke DNA Damage Cell Fate and Accelerates Emphysema Development.
Sears CR; Zhou H; Justice MJ; Fisher AJ; Saliba J; Lamb I; Wicker J; Schweitzer KS; Petrache I
Am J Respir Cell Mol Biol; 2018 Mar; 58(3):402-411. PubMed ID: 29111769
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.
Nasrallah NA; Wiese BM; Sears CR
Front Oncol; 2022; 12():846965. PubMed ID: 35530314
[TBL] [Abstract][Full Text] [Related]
17. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor.
Gozukara EM; Khan SG; Metin A; Emmert S; Busch DB; Shahlavi T; Coleman DM; Miller M; Chinsomboon N; Stefanini M; Kraemer KH
J Invest Dermatol; 2001 Aug; 117(2):197-204. PubMed ID: 11511294
[TBL] [Abstract][Full Text] [Related]
18. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C.
Macke EL; Morales-Rosado JA; Gupta A; Schmitz CT; Kruisselbrink T; Lanpher B; Klee EW
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843428
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.
Long XD; Ma Y; Zhou YF; Ma AM; Fu GH
Hepatology; 2010 Oct; 52(4):1301-9. PubMed ID: 20658464
[TBL] [Abstract][Full Text] [Related]
20. Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients.
Lai TC; Chow KC; Fang HY; Cho HC; Chen CY; Lin TY; Chiang IP; Ho SP
Oncol Rep; 2011 May; 25(5):1243-51. PubMed ID: 21327329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
